Catechins-Modified Selenium-Doped Hydroxyapatite Nanomaterials for Improved Osteosarcoma Therapy Through Generation of Reactive Oxygen Species

Osteosarcoma is the most common bone cancer with limited therapeutic options. It can be treated by selenium-doped hydroxyapatite owing to its known antitumor potential. However, a high concentration of Se is toxic toward normal and stem cells whereas its low concentration cannot effectively remove c...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Suliman, Ullah, Muhammad Wajid, Siddique, Rabeea, Liu, Yang, Ullah, Ismat, Xue, Mengzhou, Yang, Guang, Hou, Hongwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6585473/
https://www.ncbi.nlm.nih.gov/pubmed/31263675
http://dx.doi.org/10.3389/fonc.2019.00499

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6585473/
https://www.ncbi.nlm.nih.gov/pubmed/31263675
http://dx.doi.org/10.3389/fonc.2019.00499

Ejemplares similares